MedPath

山东鲁盛制药有限公司

Ownership
-
Established
2011-05-27
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

NMPA:7

Drug Approvals

Multivitamins Injection(13)

Product Name
多种维生素注射液(13)
Approval Number
国药准字H20254410
Approval Date
Jun 3, 2025
NMPA

Multivitamin for Injection (12)

Product Name
注射用多种维生素(12)
Approval Number
国药准字H20249235
Approval Date
Oct 29, 2024
NMPA

Indobufen Tablets

Product Name
吲哚布芬片
Approval Number
国药准字H20244933
Approval Date
Sep 19, 2024
NMPA

Polyethylene Glycol Electrolytes Powder(Ⅲ)

Product Name
复方聚乙二醇电解质散(Ⅲ)
Approval Number
国药准字H20234520
Approval Date
Nov 21, 2023
NMPA

Terbinafine Hydrochloride Vaginal Effervescent Tablets

Product Name
盐酸特比萘芬阴道泡腾片
Approval Number
国药准字H20183313
Approval Date
Jun 8, 2023
NMPA

Ambroxol Hydrochloride Injection

Product Name
盐酸氨溴索注射液
Approval Number
国药准字H20143266
Approval Date
May 31, 2019
NMPA

Ambroxol Hydrochloride Injection

Product Name
盐酸氨溴索注射液
Approval Number
国药准字H20143267
Approval Date
May 31, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.